February 5, 2024
Bio: House passes bill restoring full R&D expensing
On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO)…
February 1, 2024
BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative
By Jelena Ivanjac | January 30, 2024 - The end of 2023 marked the completion of Virginia’s first statewide life sciences initiative, Virginia Bio-Connect,…
February 1, 2024
GEN: Top 10 Biopharma Takeover Targets of 2024
By Alex Philippidis - February 1, 2024 - Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078…
January 31, 2024
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
ROCKVILLE, Md., Jan. 30, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the U.S. Food and…
January 31, 2024
Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology
BALTIMORE--(BUSINESS WIRE)--Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This…
